1. Market Research
  2. > Materials
  3. > Advanced Material Market Trends
  4. > Nanotechnology in Medical Devices Market by Product, Application - Global Forecast to 2019

Over the last five years, the nanotechnology-based medical devices market witnessed tremendous growth primarily due to growth in the aging population, and increasing government support with increased nanotechnology R&D expenditure and increased international research collaborations.

In this report, the global nanotechnology-based medical devices market is segmented on the basis of products and applications. On the basis products, the nanotechnology-based medical devices market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; whereas, the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the nanotechnology-based medical devices market is segmented into therapeutics applications, diagnostics applications, and research applications.

The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent.

Active implantable devices accounted for a major share of the nanotechnology-based medical devices the market. The nanotechnology-based medical devices market for active implantable devices is primarily driven by the growing incidence of age-related disorders such as hearing and cardiovascular disorders. In addition, the growing awareness about these diseases and increased acceptance of the hearing aid devices are further driving the market for active implantable devices.

In 2013, North America accounted for the largest share to the global nanotechnology-based medical devices market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, rising adoption of advanced nanotechnology-based medical devices, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global nanotechnology-based medical devices market is dominated by six players that accounted for around 65-70% of the global market in 2014. The major players in the global nanotechnology-based medical devices market are Stryker Corporation (U.S.), 3M Company (U.S.), St. Jude Medical, Inc. (U.S.), Affymetrix, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Starkey Hearing Technologies (U.S.), and Smith & Nephew plc (U.K.).

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nanotechnology-based medical devices market. The report analyzes the nanotechnology-based medical devices market by products and applications across all regions
- Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the nanotechnology-based medical devices market
- Market Development: Comprehensive information on the lucrative emerging markets by product, application, and region
- Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the nanotechnology-based medical devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the nanotechnology-based medical devices market

Table Of Contents

Nanotechnology in Medical Devices Market by Product, Application - Global Forecast to 2019
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY AND PRICING 20
1.5 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.2 MARKET SIZE ESTIMATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 MARKET SHARE ESTIMATION 25
2.5 KEY DATA FROM SECONDARY SOURCES 26
2.6 KEY DATA FROM PRIMARY SOURCES 26
2.6.1 KEY INDUSTRY INSIGHTS 27
2.7 ASSUMPTIONS FOR THE STUDY 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 32
4.1 GROWTH POTENTIAL OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET 32
4.2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC MIX 33
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN ASIA-PACIFIC 34
4.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35
4.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION: GEOGRAPHIC MIX 36
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE 38
5.2.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION 39
5.3 KEY MARKET DYNAMICS 39
5.3.1 MARKET DRIVERS 40
5.3.1.1 Increasing government support 40
5.3.1.2 Growing geriatric population 41
5.3.2 MARKET RESTRAINTS 42
5.3.2.1 Stringent and time-consuming product approval processes 42
5.3.2.2 High prices of nanotechnology-based medical devices 43
5.3.3 MARKET OPPORTUNITIES 43
5.3.3.1 Rich mid-to-late stage product pipeline 44
5.3.3.2 High growth opportunities in emerging markets 44
5.3.4 MARKET CHALLENGES 45
5.3.4.1 Commercialization of nanotechnology-based devices 45
5.3.4.2 Inadequate standards and lack of regulatory approval frameworks 46
6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 VALUE CHAIN ANALYSIS 47
6.3 INDUSTRY TRENDS 49
6.3.1 INCREASING TREND TOWARDS INTERNATIONAL COLLABORATIONS 50
6.3.2 RISING NUMBER OF PUBLIC-PRIVATE PARTNERSHIPS 50
6.4 PORTER'S FIVE FORCES ANALYSIS 51
6.4.1 THREAT OF NEW ENTRANTS 51
6.4.2 THREAT OF SUBSTITUTES 52
6.4.3 BARGAINING POWER OF SUPPLIERS 52
6.4.4 BARGAINING POWER OF BUYERS 52
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 52
7 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET,
BY PRODUCT 53
7.1 INTRODUCTION 54
7.2 ACTIVE IMPLANTABLE DEVICES 56
7.2.1 CARDIAC RHYTHM MANAGEMENT DEVICES 58
7.2.2 HEARING AID DEVICES 59
7.2.3 RETINAL IMPLANTS 60
7.3 BIOCHIPS 62
7.3.1 DNA MICROARRAYS 64
7.3.2 LAB-ON-A-CHIP 65
7.4 IMPLANTABLE MATERIALS 67
7.4.1 BONE SUBSTITUTE MATERIALS 69
7.4.2 DENTAL RESTORATIVE MATERIALS 70
7.5 MEDICAL TEXTILES AND WOUND DRESSINGS 72
7.6 OTHERS 74

8 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION 76
8.1 INTRODUCTION 77
8.2 THERAPEUTIC APPLICATIONS 78
8.3 RESEARCH APPLICATIONS 80
8.4 DIAGNOSTIC APPLICATIONS 82
9 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY REGION 84
9.1 INTRODUCTION 85
9.2 NORTH AMERICA 87
9.2.1 U.S. 91
9.2.2 CANADA 94
9.3 EUROPE 97
9.3.1 GERMANY 100
9.3.2 FRANCE 103
9.3.3 U.K. 106
9.3.4 ITALY 108
9.3.5 SPAIN 110
9.3.6 REST OF EUROPE 113
9.4 ASIA-PACIFIC 116
9.4.1 JAPAN 120
9.4.2 CHINA 123
9.4.3 INDIA 126
9.4.4 REST OF ASIA-PACIFIC 129
9.5 REST OF THE WORLD (ROW) 132
9.5.1 LATIN AMERICA 134
9.5.2 MIDDLE EAST AND AFRICA 137
10 COMPETITIVE LANDSCAPE 140
10.1 OVERVIEW 140
10.2 MARKET SHARE ANALYSIS 141
10.3 COMPETITIVE SITUATION AND TRENDS 143
10.4 NEW PRODUCT LAUNCHES 144
10.5 MERGERS AND ACQUISITIONS 145
10.6 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 146
10.7 OTHERS 146
11 COMPANY PROFILES 148
(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 148
11.2 ST. JUDE MEDICAL, INC. 149
11.3 PERKINELMER, INC. 152
11.4 STARKEY HEARING TECHNOLOGIES 154
11.5 STRYKER CORPORATION 155
11.6 AFFYMETRIX, INC. 157
11.7 3M COMPANY 159
11.8 SMITH and NEPHEW PLC 162
11.9 MITSUI CHEMICALS, INC. 164
11.10 DENTSPLY INTERNATIONAL 167
11.11 AAP IMPLANTATE AG 169
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
12 APPENDIX 171
12.1 INSIGHTS OF INDUSTRY EXPERTS 171
12.2 DISCUSSION GUIDE 172
12.3 AVAILABLE CUSTOMIZATIONS 174
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 175
12.5 RELATED REPORTS 177


LIST OF TABLES

TABLE 1 INCREASING GOVERNMENT SUPPORT FUELING GROWTH OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET 40
TABLE 2 STRINGENT PRODUCT APPROVAL PROCESSES HINDERING THE GROWTH OF NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET 42
TABLE 3 COMMERCIALIZATION OF NANOTECHNOLOGY-BASED DEVICES PRESENT A MAJOR CHALLENGE FOR THE GROWTH OF NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET 45
TABLE 4 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 55
TABLE 5 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 55
TABLE 6 GLOBAL NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 56
TABLE 7 GLOBAL NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 57
TABLE 8 GLOBAL NANOTECHNOLOGY-BASED CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 58
TABLE 9 GLOBAL NANOTECHNOLOGY-BASED HEARING AID DEVICES MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 60
TABLE 10 GLOBAL NANOTECHNOLOGY-BASED RETINAL IMPLANTS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 61
TABLE 11 GLOBAL NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 62
TABLE 12 GLOBAL NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 63
TABLE 13 GLOBAL NANOTECHNOLOGY-BASED DNA MICROARRAYS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 65
TABLE 14 GLOBAL NANOTECHNOLOGY-BASED LAB-ON-CHIPS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 66
TABLE 15 GLOBAL NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 68
TABLE 16 GLOBAL NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 68
TABLE 17 GLOBAL NANOTECHNOLOGY-BASED BONE SUBSTITUTE MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 70
TABLE 18 GLOBAL NANOTECHNOLOGY-BASED DENTAL RESTORATIVE MATERIALS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 71
TABLE 19 GLOBAL NANOTECHNOLOGY-BASED MEDICAL TEXTILES AND WOUND DRESSINGS MARKET SIZE, BY GEOGRAPHY, 2012-2019 ($MILLION) 73
TABLE 20 GLOBAL OTHER NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY GEOGRAPHY, 2012-2019 ($MILLION) 75
TABLE 21 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 78
TABLE 22 GLOBAL NANOTEHCNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2012-2019 ($MILLION) 79
TABLE 23 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR RESEARCH APPLICATIONS, BY GEOGRAPHY, 2012-2019 ($MILLION) 81
TABLE 24 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY GEOGRAPHY, 2012-2019 ($MILLION) 83
TABLE 25 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY COUNTRY, 2012-2019 ($MILLION) 88
TABLE 26 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 89
TABLE 27 NORTH AMERICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 89
TABLE 28 NORTH AMERICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 90
TABLE 29 NORTH AMERICA: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 90
TABLE 30 NORTH AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 90
TABLE 31 U.S.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 92
TABLE 32 U.S.: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 92
TABLE 33 U.S.: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 93
TABLE 34 U.S.: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 93
TABLE 35 U.S.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 93
TABLE 36 CANADA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 95
TABLE 37 CANADA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 95
TABLE 38 CANADA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 96
TABLE 39 CANADA: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 96
TABLE 40 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY COUNTRY/REGION, 2012-2019 ($MILLION) 98
TABLE 41 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 98
TABLE 42 EUROPE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 99
TABLE 43 EUROPE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 99
TABLE 44 EUROPE: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 99
TABLE 45 EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 100
TABLE 46 GERMANY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 101
TABLE 47 GERMANY: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 102
TABLE 48 GERMANY: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 102
TABLE 49 GERMANY: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 102
TABLE 50 GERMANY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 103
TABLE 51 FRANCE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 104
TABLE 52 FRANCE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 104
TABLE 53 FRANCE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 105
TABLE 54 FRANCE: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 105
TABLE 55 FRANCE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 105
TABLE 56 U.K.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 106
TABLE 57 U.K.: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 107
TABLE 58 U.K.: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 107
TABLE 59 U.K.: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 107
TABLE 60 U.K.: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 108
TABLE 61 ITALY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 109
TABLE 62 ITALY: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 109
TABLE 63 ITALY: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 109
TABLE 64 ITALY: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 110
TABLE 65 ITALY: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 110
TABLE 66 SPAIN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 111
TABLE 67 SPAIN: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 112
TABLE 68 SPAIN: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 112
TABLE 69 SPAIN: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 112
TABLE 70 SPAIN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 113
TABLE 71 REST OF EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 114
TABLE 72 REST OF EUROPE: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 114
TABLE 73 REST OF EUROPE: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 114
TABLE 74 REST OF EUROPE: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 115
TABLE 75 REST OF EUROPE: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 115
TABLE 76 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY COUNTRY/REGION, 2012-2019 ($MILLION) 117
TABLE 77 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 118
TABLE 78 ASIA-PACIFIC: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 118
TABLE 79 ASIA-PACIFIC: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 119
TABLE 80 ASIA-PACIFIC: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 119
TABLE 81 ASIA-PACIFIC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 119
TABLE 82 JAPAN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 121
TABLE 83 JAPAN: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 121
TABLE 84 JAPAN: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 122
TABLE 85 JAPAN: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 122
TABLE 86 JAPAN: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 122
TABLE 87 CHINA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 124
TABLE 88 CHINA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 124
TABLE 89 CHINA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 125
TABLE 90 CHINA: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 125
TABLE 91 CHINA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 125
TABLE 92 INDIA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 127
TABLE 93 INDIA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 127
TABLE 94 INDIA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 128
TABLE 95 INDIA: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 128
TABLE 96 INDIA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 128
TABLE 97 ROAPAC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 129
TABLE 98 ROAPAC: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 130
TABLE 99 ROAPAC: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 130
TABLE 100 ROAPAC: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 130
TABLE 101 ROAPAC: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 131
TABLE 102 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY REGION, 2012-2019 ($MILLION) 132
TABLE 103 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 132
TABLE 104 ROW: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 133
TABLE 105 ROW: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 133
TABLE 106 ROW: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 133
TABLE 107 ROW: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 134
TABLE 108 LATIN AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 135
TABLE 109 LATIN AMERICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 135
TABLE 110 LATIN AMERICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 136
TABLE 111 LATIN AMERICA: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 136
TABLE 112 LATIN AMERICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE,
BY APPLICATION, 2012-2019 ($MILLION) 136
TABLE 113 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 138
TABLE 114 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED ACTIVE IMPLANTABLE DEVICES MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 138
TABLE 115 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED BIOCHIPS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 138
TABLE 116 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 139
TABLE 117 MIDDLE EAST AND AFRICA: NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2012-2019 ($MILLION) 139
TABLE 118 RECENT DEVELOPMENTS, 2011-2015 144
TABLE 119 RECENT DEVELOPMENTS, 2011-2014 145
TABLE 120 RECENT DEVELOPMENTS, 2011-2014 146
TABLE 121 RECENT DEVELOPMENTS, 2011-2014 146


LIST OF FIGURES

FIGURE 1 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE 18
FIGURE 2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION 19
FIGURE 3 RESEARCH DESIGN 22
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23
FIGURE 5 BOTTOM-UP APPROACH 24
FIGURE 6 TOP-DOWN APPROACH 24
FIGURE 7 DATA TRIANGULATION METHODOLOGY 25
FIGURE 8 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET,
BY PRODUCT, 2014 VS. 2019 ($MILLION) 29
FIGURE 9 GLOBAL NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET,
BY TYPE, 2014 VS. 2019 ($MILLION) 29
FIGURE 10 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION, 2014 VS. 2019 ($MILLION) 30
FIGURE 11 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2014 VS. 2019 ($MILLION) 30
FIGURE 12 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SHARE, 2014 31
FIGURE 13 RISING AGING POPULATION AND GOVERNMENT SUPPORT TO DRIVE MARKET GROWTH 32
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET BY 2019 33
FIGURE 15 THERAPEUTIC APPLICATIONS SEGMENT COMMANDED THE LARGEST SHARE OF THE APAC MARKET 34
FIGURE 16 U.S. COMMANDED LION'S SHARE OF THE GLOBAL MARKET IN 2014 35
FIGURE 17 NORTH AMERICA DOMINATED THE THERAPEUTIC APPLICATIONS MARKET IN 2014 36
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD 36
FIGURE 19 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SEGMENTATION, BY TYPE 38
FIGURE 20 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SEGMENTATION,
BY APPLICATION 39
FIGURE 21 INCREASING GOVERNMENT SUPPORT TO SPUR THE DEMAND FOR NANOTECHNOLOGY-BASED MEDICAL DEVICES 39
FIGURE 22 DEMOGRAPHIC GROWTH TRENDS OF THE ELDERLY POPULATION 41
FIGURE 23 VALUE CHAIN ANALYSIS 48
FIGURE 24 RISING NUMBER OF TRANSNATIONAL AND PUBLIC-PRIVATE COLLABORATIONS TO SHAPE MARKET GROWTH 49
FIGURE 25 MASSIVE GROWTH POTENTIAL IN THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET ENHANCING COMPETITION AMONG MARKET PLAYERS 51
FIGURE 26 ACTIVE IMPLANTABLE DEVICES DOMINATE THE GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET 54
FIGURE 27 ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR ACTIVE IMPLANTABLE DEVICES 57
FIGURE 28 APAC TO REGISTER MAXIMUM GROWTH IN THE FORECAST PERIOD 63
FIGURE 29 GLOBAL NANOTECHNOLOGY-BASED IMPLANTABLE MATERIALS MARKET,
BY TYPE 2014 VS. 2019 67
FIGURE 30 THERAPEUTIC APPLICATIONS COMMANDED LARGEST SHARE OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN 2014 77
FIGURE 31 APAC TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD 79
FIGURE 32 GEOGRAPHICAL SNAPSHOT (2014-2019) - EMERGING MARKETS IN APAC REGION ARE EMERGING AS NEW HOT SPOTS 86
FIGURE 33 JAPAN OFFERS HIGHEST GROWTH POTENTIAL IN ALMOST ALL THE MARKETS 86
FIGURE 34 NORTH AMERICA NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY GROWING AGING POPULATION 88
FIGURE 35 ASIA-PACIFIC NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SNAPSHOT: GROWTH WILL BE DRIVEN BY RAPID DEVELOPMENT OF HEALTHCARE INDUSTRY 117
FIGURE 36 NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED
BY MARKET PLAYERS OVER THE LAST FOUR YEARS (2011-2014) 140
FIGURE 37 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 141
FIGURE 38 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY 143
FIGURE 39 GEOGRAPHY REVENUE MIX OF TOP MARKET PLAYERS 148
FIGURE 40 ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT 149
FIGURE 41 PERKINELMER, INC.: COMPANY SNAPSHOT 152
FIGURE 42 STRYKER CORPORATION: COMPANY SNAPSHOT 155
FIGURE 43 AFFYMETRIX, INC.: COMPANY SNAPSHOT 157
FIGURE 44 3M COMPANY: COMPANY SNAPSHOT 159
FIGURE 45 SMITH and NEPHEW PLC: COMPANY SNAPSHOT 162
FIGURE 46 MITSUI CHEMICALS, INC.: COMPANY SNAPSHOT 164
FIGURE 47 DENTSPLY INTERNATIONAL: COMPANY SNAPSHOT 167
FIGURE 48 AAP IMPLANTATE AG: COMPANY SNAPSHOT 169

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
The Maturing Nanotechnology Market: Products and Applications

The Maturing Nanotechnology Market: Products and Applications

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

The global nanotechnology market should reach $90.5 billion by 2021 from $39.2 billion in 2016 at a compound annual growth rate (CAGR) of 18.2%, from 2016 to 2021. Use this report to: - Define the creation ...

Nanotechnology to Achieve Cost Efficiencies within Global Medical Devices Value Chain (TechVision)

Nanotechnology to Achieve Cost Efficiencies within Global Medical Devices Value Chain (TechVision)

  • $ 4950
  • Industry report
  • September 2016
  • by Frost & Sullivan

Leading the Way Forward for OEMs Streamlining their Global Medical Devices Value Chain Development of nanotechnology-based medical devices enables major cost reduction across the medical device value chain, ...

Global Nanotechnology Market Analysis & Trends - Industry Forecast to 2025

Global Nanotechnology Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • September 2016
  • by Accuray Research LLP

Global Nanotechnology Market Analysis & Trends - Industry Forecast to 2025 The Global Nanotechnology Market is poised to grow at a CAGR of around 18.1% over the next decade to reach approximately $173.95 ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.